Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Operating Expenses | 5,449 | 5,009 | 0 | 0 | 0 |
| Operating Income | -5,449 | -5,009 | N/A | N/A | N/A |
| Other Income | 288 | -88 | 0 | 0 | 0 |
| Pre-tax Income | -5,161 | -5,097 | 0 | 0 | 0 |
| Net Income Continuous | -5,161 | -5,097 | N/A | N/A | N/A |
| Net Income | $-5,161 | $-5,097 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -14.50 | -14.70 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -14.47 | -14.69 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -14.50 | -14.70 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -14.47 | -14.69 | N/A | N/A | N/A |
| EBITDA(a) | $-5,191 | $-5,000 | $N/A | $N/A | $N/A |